Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete
|
March 1, 1983
[Anchoring experiments on human cadaver vertebrae using various types of screws]
W Teschner, U Manitz, F Holzweissig, et al.
Archives Internationales De Pharmacodynamie Et De Therapie
|
May 1, 1996
In vivo effect of alpha 1-acid glycoprotein on experimentally enhanced capillary permeability in guinea-pig skin
E M Muchitsch, W Teschner, Y Linnau, et al.
European Journal of Biochemistry
|
September 3, 1984
Isolation, physicochemical properties, and folding of octopine dehydrogenase from Pecten jacobaeus
G Zettlmeissl, W Teschner, R Rudolph, et al.
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete
|
January 1, 1986
[Shear fracture stress of the spongiosa and pressure fracture stress of cortical bone of cadaveric vertebrae]
U Manitz, F Holzweissig, W Teschner, et al.
Clinical and Experimental Immunology
|
June 4, 2005
Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells
K Olas, H Butterweck, W Teschner, et al.
Biochemistry
|
February 21, 1989
Ordered disruption of subunit interfaces during the stepwise reversible dissociation of Escherichia coli phosphofructokinase with KSCN
D Deville-Bonne, G Le Bras, W Teschner, et al.
Biochemistry
|
August 22, 1989
Urea-induced inactivation, dissociation, and unfolding of the allosteric phosphofructokinase from Escherichia coli
G L Bras, W Teschner, D Deville-Bonne, et al.
Vox Sanguinis
|
January 3, 2008
A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity
G Poelsler, A Berting, J Kindermann, et al.
Vox Sanguinis
|
September 9, 2006
Fc function of a new intravenous immunoglobulin product: IGIV 10% triple virally inactivated solution
B M Reipert, J Ilas, C Carnewal, et al.
Vox Sanguinis
|
December 22, 2006
A new liquid, intravenous immunoglobulin product (IGIV 10%) highly purified by a state-of-the-art process
W Teschner, H A Butterweck, W Auer, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete
|
March 1, 1983
[Anchoring experiments on human cadaver vertebrae using various types of screws]
W Teschner, U Manitz, F Holzweissig, et al.
Archives Internationales De Pharmacodynamie Et De Therapie
|
May 1, 1996
In vivo effect of alpha 1-acid glycoprotein on experimentally enhanced capillary permeability in guinea-pig skin
E M Muchitsch, W Teschner, Y Linnau, et al.
European Journal of Biochemistry
|
September 3, 1984
Isolation, physicochemical properties, and folding of octopine dehydrogenase from Pecten jacobaeus
G Zettlmeissl, W Teschner, R Rudolph, et al.
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete
|
January 1, 1986
[Shear fracture stress of the spongiosa and pressure fracture stress of cortical bone of cadaveric vertebrae]
U Manitz, F Holzweissig, W Teschner, et al.
Clinical and Experimental Immunology
|
June 4, 2005
Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells
K Olas, H Butterweck, W Teschner, et al.
Biochemistry
|
February 21, 1989
Ordered disruption of subunit interfaces during the stepwise reversible dissociation of Escherichia coli phosphofructokinase with KSCN
D Deville-Bonne, G Le Bras, W Teschner, et al.
Biochemistry
|
August 22, 1989
Urea-induced inactivation, dissociation, and unfolding of the allosteric phosphofructokinase from Escherichia coli
G L Bras, W Teschner, D Deville-Bonne, et al.
Vox Sanguinis
|
January 3, 2008
A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity
G Poelsler, A Berting, J Kindermann, et al.
Vox Sanguinis
|
September 9, 2006
Fc function of a new intravenous immunoglobulin product: IGIV 10% triple virally inactivated solution
B M Reipert, J Ilas, C Carnewal, et al.
Vox Sanguinis
|
December 22, 2006
A new liquid, intravenous immunoglobulin product (IGIV 10%) highly purified by a state-of-the-art process
W Teschner, H A Butterweck, W Auer, et al.
Page
of 3